UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y
Number of items: 284.

A

Abelman, W; Virchis, A; Yong, K; (2005) Extramedullary myeloma representing as a pericardial effusion with tamponade: Two case reports and a further review of 19 cases in the literature. LEUKEMIA & LYMPHOMA , 46 (1) pp. 137-142. 10.1080/10428190400011583.

Addison, EG; North, J; Bakhsh, I; Marden, C; Haq, S; Al-Sarraj, S; Malayeri, R; ... Lowdell, MW; + view all (2005) Ligation of CD8 alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. IMMUNOLOGY , 116 (3) 354 - 361. 10.1111/j.1365-2567.2005.02235.x. Gold open access

Aebischer, T; Bennett, CL; Pelizzola, M; Vizzardelli, C; Pavelka, N; Urbano, M; Capozzoli, M; ... Ricciardi-Castagnoli, P; + view all (2005) A critical role for lipophosphoglycan in proinflammatory responses of dendritic cells to Leishmania mexicana. EUROPEAN JOURNAL OF IMMUNOLOGY , 35 (2) pp. 476-486. 10.1002/eji.200425674.

Al-Adnani, M; Idowu, B; Yu, L; Diss, TC; Lam, L; Gale, RE; O'Dell, E; (2005) Detection of a new mutation in fibrous dysplasia using a modified site directed mutagenesis methodology. In: JOURNAL OF PATHOLOGY. (pp. 7 - 7). JOHN WILEY & SONS LTD

Al-Adnani, M; Idowu, B; Yu, T; Diss, TC; Gale, RE; O'Dell, E; Flanagan, AM; (2005) A simple and reliable method for the molecular diagnosis of fibrous dysplasia. In: MODERN PATHOLOGY. (pp. 10A - 11A). NATURE PUBLISHING GROUP

Al-Obaidi, M.S.J.; (2005) Fluorescence-in-situ hybridization in adult all cytogenetic findings and clinical correlation. Doctoral thesis , University of London. Green open access
file

Arce, F; Gatjens-Boniche, O; Vargas, E; Valverde, B; Diaz, C; (2005) Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2. CANCER LETTERS , 229 (2) pp. 271-281. 10.1016/j.canlet.2005.06.047.

Ardeshna, KM; Kakouros, N; Qian, W; Powell, MG; Saini, N; D'Sa, S; Mackinnon, S; ... Linch, DC; + view all (2005) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens. British Journal of Haematology , 130 (3) pp. 363-372. 10.1111/j.1365-2141.2005.05603.x.

Ardeshna, KM; Kakouros, N; Qian, W; Powell, MG; Saini, N; D'Sa, S; Mackinnon, S; ... Linch, DC; + view all (2005) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens. BRIT J HAEMATOL , 130 (3) 363 - 372. 10.1111/j.1365-2141.2005.05603.x.

Aydinok, Y; Evans, P; Terzi, A; Cetiner, N; Porter, JB; (2005) Randomised prospective evaluation of iron balance, chelation efficiency, urine excretion and NTBI progression with deferiprone (DFP) or deferoxamine (DFO) monotherapy or with combined DFP plus DFO. In: BLOOD. (pp. 758A - 758A). AMER SOC HEMATOLOGY

B

Bax, BE; Richfield, L; Bain, MD; Mehta, AB; Chalmers, RA; Rampling, MW; (2005) Haemorheology in Gaucher disease. European Journal of Haematology , 75 (3) pp. 252-258.

Beck, M; Cox, TM; Mehta, AB; Widmer, U; (2005) Lysosomal Diseases, Natural course, pathology and therapy. [Book]. (Vol.95, su). Taylor & Francis

Benjamin, R; Streck, C; Ng, CYC; Singh, N; Khwaja, A; Pizzey, A; McIntosh, J; ... Nathwani, AC; + view all (2005) Effect of substained expression of human interferon-β by rAAV vector medicated gene transfer in xenograft models of acute leukaemia. In:

Bennett, CL; van Rijn, E; Jung, S; Inaba, K; Steinman, RM; Kapsenberg, ML; Clausen, BE; (2005) Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. JOURNAL OF CELL BIOLOGY , 169 (4) pp. 569-576. 10.1083/jcb.200501071. Green open access
file

Betticher, D; von Rohr, A; Kovacsovics, T; Martinelli, G; Cerny, T; Linch, DC; Dyer, MJS; ... Cina, S; + view all (2005) Sequential high-dose chemotherapy (SHDC) with autologous stem cell transplantation (ASCT) vs standard CHOP regimen for pts with untreated aggressive NHL. Result of the mistral trial from the Swiss Group for Clinical Cancer Research (SAKK). In: ANNALS OF ONCOLOGY. (pp. 100 - 101). OXFORD UNIV PRESS

Bloor, AJC; Thomson, K; Cooper, N; Peggs, KS; Mackinnon, S; (2005) Dose-escalated donor lymphocyte infusions post allogeneic transplantation in non-Hodgkin's lymphoma. In: BLOOD. (pp. 569A - 570A). AMER SOC HEMATOLOGY

Bochtler, W; Beth, M; Marsh, SGE; Muller, CR; (2005) Hlacore - A comprehensive low level HLA library for programmers. In: (Proceedings) 31st Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. S49-S49). ELSEVIER SCIENCE INC

Bowen, DT; Frew, ME; Hills, R; Gale, RE; Wheatley, K; Groves, MJ; Langabeer, SE; ... Linch, DC; + view all (2005) RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years. BLOOD , 106 (6) 2113 - 2119. 10.1182/blood-2005-03-0867.

Burton, C; Smith, P; Vaughan-Hudson, G; Qian, W; Hoskin, P; Cunningham, D; Hancock, B; (2005) Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. British Journal of Haematology , 130 (4) pp. 536-541. 10.1111/j.1365-2141.2005.05640.x.

C

Cahetterjee, R; Palla, K; McGarrigle, HH; Mackinnon, S; Kottaridis, PD; (2005) Syndrome 'X' in adult female recipients of bone marrow transplantation for haematological malignancies. Bone Marrow Transplantation , 35 321-.

Camilleri, RS; Cohen, H; (2005) No association between pulmonary embolism or deep vein thrombosis and the -455G/A beta-fibrinogen gene polymorphism. BLOOD COAGUL FIBRIN , 16 (3) 193 - 198.

Camilleri, RS; Mackie, IJ; Scully, M; Machin, SJ; Cohen, H; (2005) A genetic basis for adult onset TTP? In: BLOOD. (pp. 357A - 357A). AMER SOC HEMATOLOGY

Cardigan, R; Lawrie, AS; Mackie, IJ; Williamson, LM; (2005) The Quality of Fresh-Frozen Plasma (FFP) Produced from Whole Blood Stored at 4°C Overnight. Transfusion , 45 pp. 1342-1348.

Cardigan, R; Lawrie, AS; Mackie, IJ; Williamson, LM; (2005) The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight. TRANSFUSION , 45 (8) 1342 - 1348. 10.1111/j.1537-2995.2005.00219.x.

Charrier, S; Dupre, L; Blundell, M; Scaramuzza, S; Jeanson, L; Vainchenker, W; Danos, O; ... Galy, A; + view all (2005) Functional correction of lymphocytes and dendritic cells of patients with WAS or XLT, using lentiviral vectors targeting the expression of WAS protein to hematopoietic cells. Blood , 106 (11) 852A-852A.

Charrier, S; Stockholm, D; Seye, K; Opolon, P; Taveau, M; Gross, D-A; Bucher-Laurent, S; ... Galy, A; + view all (2005) A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther , 12 (7) pp. 597-606. 10.1038/sj.gt.3302440.

Chatterjee, R; Palla, K; McGarrigle, HH; Mckinnon, S; Kottaridis, PD; (2005) Syndrome 'X' in adult female recipients of bone marrow transplantation for haematological malignancies. BONE MARROW TRANSPL , 35 (2) 209 - 210. 10.1038/sj.bmt.1704744.

Chatterjee, R; Shah, F; Davis, B; Byers, DM; Sooranna, S; Bajoria, R; Pringle, J; (2005) Prospective study of histomormometry, biochemical bone markers and bone densitometric response to pamidronate in beta-thalassaemia presenting with osteoporosis. In: JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION. (pp. 375A - 376A). ELSEVIER SCIENCE INC

Cheung, CW; Burton, C; Smith, P; Linch, DC; Hoskin, PJ; Ardeshina, KM; (2005) Central nervous system chemoprophylaxis in non-Hodgkin's lymphoma: A questionnaire-based survey evaluating current practice in the United Kingdom. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 26 - 27). BLACKWELL PUBLISHING

Cheung, CW; Burton, C; Smith, P; Linch, DC; Hoskin, PJ; Ardeshna, KM; (2005) Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK. BRIT J HAEMATOL , 131 (2) 193 - 200. 10.1111/j.1365-2141.2005.05756.x.

Cheung, CW; Burton, C; Smith, P; Linch, DC; Hoskin, PJ; Ardeshna, KM; (2005) Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK (vol 131, pg 193, 2005). BRIT J HAEMATOL , 131 (5) 673 - 673.

Clarke, DL; Belvisi, MG; Smith, SJ; Hardaker, E; Yacoub, MH; Meja, KK; Newton, R; ... Giembycz, MA; + view all (2005) Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol , 288 (2) L238-L250. 10.1152/ajplung.00313.2004.

Coakley, M; Self, R; Marchant, W; Mackie, I; Mallett, SV; Mythen, M; (2005) Use of the platelet function analyser (PFA-100 (R)) to quantify the effect of low dose aspirin in patients with ischaemic heart disease. ANAESTHESIA , 60 (12) 1173 - 1178. 10.1111/j.1365-2044.2005.04291.x.

Cobbold, M; Khan, N; Pourgheysari, B; Tauro, S; McDonald, D; Osman, H; Assenmacher, M; ... Moss, PAH; + view all (2005) Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J EXP MED , 202 (3) 379 - 386. 10.1084/jem.20040613.

Cohen, H; (2005) Analysis of the Sliding Window Powering Algorithm. J. Cryptology , 18 (1) pp. 63-76.

Cohen, H; (2005) Inherited thrombophilia and pregnancy loss-epidemiology. THROMBOSIS RESEARCH , 115 13 - 17.

Cohen, H; Scully, M; Starke, R; Mackie, I; Machin, S; (2005) Successful pregnancy outcome of three patients with chronic, unremitting Thrombotic Thrombocytopenic Purpura. In: THROMBOSIS RESEARCH. (pp. 116 - 116). PERGAMON-ELSEVIER SCIENCE LTD

Collin, MP; Hart, DN; Jackson, GH; Cook, G; Cavet, J; Mackinnon, S; Dickinson, AM; (2005) The fate of human Langerhans cells in hematopoietic stem cell transplantation. In: BLOOD. (pp. 170A - 170A). AMER SOC HEMATOLOGY

Cooper, N; Avivi, I; Karl, PS; Hart, DQ; Thomson, K; Bloor, AJC; Goldstone, AH; ... Mackinnon, S; + view all (2005) The use of PET scans to direct immunotherapy following reduced intensity stem cell transplants in adults with lymphoid malignancies. In: BLOOD. (pp. 438B - 438B). AMER SOC HEMATOLOGY

Crawley, C; Lalancette, M; Szydlo, R; Gilleece, M; Peggs, K; Mackinnon, S; Juliusson, G; ... Chronic Leukaemia Working Party EB, ; + view all (2005) Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. BLOOD , 105 (11) 4532 - 4539. 10.1182/blood-2004-06-2387.

D

Davidoff, AM; Gray, JT; Ng, CYC; Zhang, YB; Zhou, JF; Spence, Y; Bakar, Y; (2005) Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models. MOL THER , 11 (6) 875 - 888. 10.1016/j.ymthe.2004.12.022.

Davidoff, AM; Ng, CYC; Zhang, YB; Streck, CJ; Mabry, SJ; Barton, SH; Baudino, T; ... Nathwani, AC; + view all (2005) Careful decoy receptor titering is required to inhibit tumor angiogenesis while avoiding adversely altering VEGF bioavailability. MOL THER , 11 (2) 300 - 310. 10.1016/j.ymthe.2004.09.014.

Davies, J.; (2005) Selective depletion of alloreactive T cells to reduce graft-versus-host disease and enhance immune reconstitution post allogeneic haematopoietic stem cell transplantation. Doctoral thesis , University of London. Green open access
file

Delgado, J; Thomson, K; Russell, N; Ewing, J; Stewart, W; Cook, G; Devereux, S; ... Milligan, D; + view all (2005) Results of alemtuzumab-based reduced-intensity allogeneic transplantation for advanced chronic lymphocytic leukemia: A BSBMT study. In: BLOOD. (pp. 813A - 813A). AMER SOC HEMATOLOGY

Dickson, PV; Nathwani, AC; Davidoff, AM; (2005) Delivery of antiangiogenic agents for cancer gene therapy. TECHNOL CANCER RES T , 4 (4) 331 - 341.

Dotti, G; Savoldo, B; Pule, M; Straathof, KC; Biagi, E; Yvon, E; Vigouroux, S; ... Rooney, CM; + view all (2005) lHuman cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. BLOOD , 105 (12) 4677 - 4684. 10.1182/blood-2004-08-3337. Green open access
file

Duarte, RF; Delgado, J; Shaw, BE; Wrench, DJ; Ethell, A; Patch, D; Dhillon, AP; ... Quaglia, AFE; + view all (2005) Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver. BIOL BLOOD MARROW TR , 11 (10) 805 - 813. 10.1016/j.bbmt.2005.06.008.

Duarte, RF; Delgado, J; Shaw, BE; Wrench, DJ; Ethell, M; Patch, D; Dhillon, AP; ... Quaglia, AF; + view all (2005) Histological features in the liver biopsy predict the clinical outcome of patients with graft-versus-host disease of the liver. In: BONE MARROW TRANSPLANTATION. (pp. S43 - S43). NATURE PUBLISHING GROUP

Duarte, RF; Delgado, J; Shaw, BE; Wrench D J, E; M, P; D, D; A P, M; ... A, F; + view all (2005) Histologic features of the liver biopsy predict the clinical outcome for patients with graft-verus-host disease of the liver. Biology of Blood and Marrow Transplantation , 11 pp. 805-813.

de Groot, NG; Garcia, CA; Verschoor, EJ; Doxiadis, GGM; Marsh, SGE; Otting, N; Bontrop, RE; (2005) Reduced MIC gene repertoire variation in west African chimpanzees as compared to humans. MOLECULAR BIOLOGY AND EVOLUTION , 22 (6) pp. 1375-1385. 10.1093/molbev/msi127.

E

Enver, T; Tsuzuki, S; Brown, J; Hong, DL; Gupta, R; Ford, T; Egucchi, MI; ... Greaves, M; + view all (2005) Developmental impact of leukemic fusion genes on stem cell fate. HEMATOPOIETIC STEM CELLS V , 1044 pp. 16-23. 10.1196/annals.1349.003.

F

Fielding, AK; (2005) Measles as a potential oncolytic virus. REV MED VIROL , 15 (2) 135 - 142. 10.1002/rmv.455.

Fitzmaurice, DA; Gardiner, C; Kitchen, S; Mackie, I; Murray, ET; Machin, SJ; Brit Soc Haematology Taskforce Hae, ; (2005) An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation. BRIT J HAEMATOL , 131 (2) 156 - 165. 10.1111/j.1365-2141.2005.05739.x.

Foroni, L; Mitchell, W; Rai, LJ; Casanova, A; Gerrard, G; Patel, B; Richards, S; ... Goldstone, AH; + view all (2005) Molecular monitoring of residual disease (MRD) during induction and intensification phases in low risk adult B cell ALL treated according to the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 423A). AMER SOC HEMATOLOGY

Foroni, L; Mitchell, W; Rai, LJ; Casanova, A; Patel, B; Richards, S; Fielding, A; (2005) Value of molecular monitoring for minimal residual disease preceding autologous SCT following diagnosis of B cell acute lymphoblastic leukemia in patients treated with the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 424A). AMER SOC HEMATOLOGY

Foroni, L; Mitchell, W; Rai, LJ; Richards, S; Fielding, A; Goldstone, AH; (2005) The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 423A). AMER SOC HEMATOLOGY

Freeman, L; Hewison, M; Hughes, SV; Evans, KN; Hardie, D; Means, TK; Chakraverty, R; (2005) Expression of 11 beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells. BLOOD , 106 (6) 2042 - 2049. 10.1182/blood-2005-01-0186.

G

Gale, RE; Hills, R; Kottaridis, P; Srirangan, S; Wheatley, K; Burnett, A; Linch, DC; (2005) No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials. Blood , 106 (10) pp. 3658-3665. 10.1182/blood-2005-03-1323.

Gale, RE; Hills, R; Kottaridis, PD; Srirangan, S; Wheatley, K; Burnett, AK; Linch, DC; (2005) No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials. BLOOD , 106 (10) 3658 - 3665. 10.1182/blood-2005-03-1323. Green open access
file

Gale, RE; Hills, R; Pizzey, AR; Kottaridis, PD; Swirsky, D; Gilkes, AF; Nugent, E; ... NCRI Adult Leukaemia Working Party, ; + view all (2005) Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. BLOOD , 106 (12) 3768 - 3776. Green open access
file

Gale, RE; Hills, R; Pizzey, AR; Kottaridis, PD; Swirsky, D; Gilkes, AF; Nugent, E; ... Grimwade, DNCRIALWP; + view all (2005) Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. Blood , 106 (12) pp. 3768-3776. 10.1182/blood-2005-04-1746.

Ganeshaguru, K; Folarin, NI; Baker, RJ; Casanova, AM; Bhimjiyani, A; Hoffbrand, AV; Mehta, AB; (2005) An in vitro model of proliferating CLL cells for drug sensitivity analysis. In: BLOOD. (pp. 829A - 829A). AMER SOC HEMATOLOGY

Gardiner, C; Pennaneac'h, C; Walford, C; Machin, SJ; Mackie, IJ; (2005) An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. BRIT J HAEMATOL , 128 (6) 842 - 848. 10.1111/j.1365-2141.2005.05394.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. BRIT J HAEMATOL , 128 (2) 242 - 247. 10.1111/j.1365.2141.2004.05300.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol , 128 (2) pp. 242-247. 10.1111/j.1365-2141.2004.05300.x.

Gardiner, C; Williams, KE; Mackie, IJ; Machin, SJ; Cohen, H; (2005) A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 11 - 11). BLACKWELL PUBLISHING

Gardiner, C; Williams, KE; Mackie, IJ; Machin, SJ; Cohen, H; (2005) A randomised controlled trial of patient self management of oral anticoagulation compared with patient self-testing. In: (Proceedings) British society for haematology annual scientific meeting.

Gardiner, C.; Pennaneac'h, C.; Walford, C.; Machin, S.J.; Mackie, I.J.; (2005) An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. British Journal of Haematology , 128 (6) pp. 842-848. 10.1111/j.1365-2141.2005.05394.x.

Gerrard, G; Butters, TD; Ganeshaguru, K; Mehta, A; (2005) Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. European Journal of Pharmacology , 609 (1-3) pp. 34-39.

Ginsberg, L; Valentine, A; Mehta, A; (2005) Neurological rarity - Fabry disease. Practical Neurology , 5 (2) pp. 110-113. 10.1111/j.1474-7766.2005.00275.x.

Glasow, A; Barrett, A; Gupta, R; Grimwade, D; von Lindern, M; Enver, T; Zelent, A; (2005) Expression of ATRA inducible RAR alpha 2 isoform is deregulated in AML. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 351A-351A). AMER SOC HEMATOLOGY

Glassford, J; Brosens, JJ; Turner, M; Lam, EWEA; (2005) Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes. European Journal of Immunology , 95 (9) pp. 2748-2761.

Gomez, K; McVey, JH; Tuddenham, E; (2005) Inhibition of coagulation by macromolecular complexes. Haematologica , 90 (11) pp. 1570-1576. Gold open access

Gomez-Escobar, N; Bennett, C; Prieto-Lafuente, L; Aebischer, T; Blackburn, CC; Maizels, RM; (2005) Heterologous expression of the filarial nematode alt gene products reveals their potential to inhibit immune function. BMC Biology , 3 , Article 108. 10.1186/1741-7007-3-8. Green open access
file

Gondek, DC; Lu, LF; Quezada, SA; Sakaguchi, S; Noelle, RJ; (2005) Cutting edge: Contact-mediated suppression by CD4(+)-CD25(+) regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J IMMUNOL , 174 (4) 1783 - 1786.

Grandage, VL; Gale, RE; Lich, DC; Khwaja, A; (2005) PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-κB, MAPkinase and p53 pathways. Leukemia , 19 (4) pp. 586-594. 10.1038/sj.leu.2403653.

Grandage, VL; Gale, RE; Linch, DC; Khwaja, A; (2005) PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappa B, MAPkinase and p53 pathways. LEUKEMIA , 19 (4) 586 - 594. 10.1038/sj.leu.2403653.

Grandage, VL; Linch, DC; Khwaja, A; (2005) Go6976 is a novel and potent inhibitor of JAK2 and JAK3 tyrosine kinases both in vitro and in cellular assays. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 6 - 6). BLACKWELL PUBLISHING

Grandage, VL; Linch, DC; Khwaja, A; (2005) Go6976, a novel and potent inhibitor of JAK2 and JAK3, reduces constitutive STAT activity and induces apoptosis in myeloid leukaemia and anaplastic lymphoma cells. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 40 - 40). BLACKWELL PUBLISHING

Gregg, R; Smith, CM; Clark, FJ; Dunnion, D; Khan, N; Chakraverty, R; Nayak, L; (2005) The number of human peripheral blood CD4(+) CD25(high) regulatory T cells increases with age. CLIN EXP IMMUNOL , 140 (3) 540 - 546. 10.1111/j.1365-2249.2005.02798.x.

H

Haines, BP; Gupta, R; Jones, CM; Summerbell, D; Rigby, PWJ; (2005) The NLRR gene family and mouse development: Modified differential display PCR identifies NLRR-1 as a gene expressed in early somitic myoblasts. Dev Biol , 281 (2) pp. 145-159. 10.1016/j.ydbio.2005.01.030.

Harris, C; Hughes, D; Budge, F; Mehta, A; (2005) SACCADIC EYE MOVEMENTS IN D409H-N370S GAUCHER HETEROZYGOTES. Presented at: UNSPECIFIED.

Harrison, CN; et, A; (2005) Hydroxyurea compared with anegralide in high risk essential thrombocythaemia. New England Journal of Medicine , 353 (1) pp. 33-45.

Harrison, P; Mackie, I; Mathur, A; Robinson, MSC; Hong, Y; Erusalimsky, JD; Machin, SJ; (2005) Platelet hyper-function in acute coronary syndromes. BLOOD COAGUL FIBRIN , 16 (8) 557 - 562.

Hart, DP; Avivi, I; Thomson, KJ; Peggs, KS; Morris, EC; Goldstone, AH; Linch, DC; ... Mackinnon, S; + view all (2005) Use of F-18-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions. BRIT J HAEMATOL , 128 (6) 824 - 829. 10.1111/j.1365-2141.2005.05388.x.

Hart, DP; Avivi, I; Thomson, KJ; Peggs, KS; Morris, EC; Goldstone, AH; Linch, DC; ... Mackinnon, S; + view all (2005) Use of<sup>18</sup>F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions. British Journal of Haematology , 128 (6) pp. 824-829. 10.1111/j.1365-2141.2005.05388.x.

Hoffmann, B; de Lorenzo, AG; Mehta, A; Beck, M; Widmer, U; Ricci, R; (2005) Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey). JOURNAL OF MEDICAL GENETICS , 42 (3) pp. 247-252. 10.1136/jmg.2004.025791.

Hoskin, PJ; Smith, P; Maughan, TS; Gilson, D; Vernon, C; Syndikus, I; Linch, DC; (2005) Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma. Clinical Oncology , 17 (1) pp. 47-53. 10.1016/j.clon.2004.07.004.

Hoskin, PJ; Smith, P; Maughan, TS; Gilson, D; Vernon, C; Syndikus, I; Linch, DC; (2005) Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma. CLIN ONCOL-UK , 17 (1) 47 - 53. 10.1016/j.clon.2004.07.004.

Hough, R; Chetwood, A; Sinfield, R; Welch, J; Vora, A; (2005) Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , 27 (2) pp. 67-72. 10.1097/01.mph.0000153958.95486.6f.

Hughes, D; Baker, R; Richfield, L; Milligan, A; Goodwin, S; Blincoe, M; Bruce, R; (2005) BALANCED ORAL SUBSTRATE REDUCTION THERAPY FOR PATIENTS WITH MILD TO MODERATE GAUCHER DISEASE: ONE YEAR IN CLINICAL PRACTICE. Presented at: UNSPECIFIED.

Hughes, DA; Mehta, AB; (2005) Vascular complications of Fabry disease: enzyme replacement and other therapies. In: ACTA PAEDIATRICA. (pp. 28 - 33). TAYLOR & FRANCIS AS

Hughes, DA; Mehta, AB; (2005) Vascular complications of Fabry disease: enzyme replacement and other therapies. Acta Paediatr Suppl , 94 (447) pp. 28-33. 10.1111/j.1651-2227.2005.tb02107.x.

Hunter, HM; Peggs, K; Powles, R; Rahemtulla, A; Mahendra, P; Cavenagh, J; Littlewood, T; ... Clinical Trials Comm British Soc, ; + view all (2005) Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning - evidence for a superior outcome using melphalan combined with total body irradiation. BRIT J HAEMATOL , 128 (4) 496 - 502. 10.1111/j.1365-2141.2004.05330.x.

J

Jacobs, EMG; Hendriks, JCM; van Tits, BLJH; Evans, PJ; Breuer, W; Liu, DY; Jansen, EHJM; ... Swinkels, DW; + view all (2005) Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform. ANAL BIOCHEM , 341 (2) 241 - 250. 10.1016/j.ab.2005.03.008.

Jalal, H; Bibby, DF; Tang, JW; Bennett, J; Kyriakou, C; Peggs, K; Cubitt, D; ... Tedder, RS; + view all (2005) First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults. J CLIN MICROBIOL , 43 (6) 2575 - 2580. 10.1128/JCM.43.6.2575-2580.2005.

Jenny, C; Toublanc, E; Danos, O; Merten, O-W; (2005) Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells. Cytotechnology , 49 (1) pp. 11-23. 10.1007/s10616-005-5361-z.

Jewell, AP; Cochrane, M; McIntosh, J; Benjamin, R; Nathwani, A; (2005) Comparison of viral vectors for gene transfer into CLL cells: Efficient transduction with adeno-associated virus-8 (AAV-8). In: BLOOD. (pp. 837A - 837A). AMER SOC HEMATOLOGY

K

Kirk, P; Firmin, DN; Sampson, B; Porter, JB; Walker, MJ; Pennell, DJ; (2005) Validation of T2*technique in ex-vivo myocardial tissue. In: BLOOD. (pp. 7B - 7B). AMER SOC HEMATOLOGY

Kleinert, J; Dehout, F; Schwarting, A; de, LAG; Ricci, R; Kampmann, C; Beck, M; ... Sunder-Plassmann, G; + view all (2005) Anemia is a new complication in Fabry disease: data from the Fabry Outcome Survey. Kidney International , 67 (5) pp. 1955-1960.

Knowles, S; Milkins, C; Stainsby, D; Jones, H; Cohen, H; (2005) Haemolytic transfusion reactions - how many are preventable? In: (Proceedings) British society for haematology annual scientific meeting.

Kogelberg, H; Tolner, B; Lowdell, M; Qureshi, U; Robson, M; Dearling, JL; Pedley, RB; ... Chester, KA; + view all (2005) Mechansims of clearance of the antibody-directed enzyme prodrug therapeutic, the mannosylated MFE-CP. In: (Proceedings) NCRI Cancer Conference Proceedings.

Kroger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; ... German Cooperative Transplant Grp, ; + view all (2005) Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. BRIT J HAEMATOL , 129 (5) 631 - 643. 10.1111/j.1365-2141.2005.05513.x.

Kroger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; ... Marks, D; + view all (2005) Comparison between anti-thymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch in melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated SCT in patients with multiple myeloma. In: BONE MARROW TRANSPLANTATION. (pp. S49 - S49). NATURE PUBLISHING GROUP

Kröger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; ... Marks, DI; + view all (2005) Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. British Journal of Haematology , 129 (5) pp. 631-643. 10.1111/j.1365-2141.2005.05513.x.

Kyriakou, C; Attygalle, A; Linch, D; Goldstone, A; Smith, P; Dogan, A; (2005) Angioimmunoblastic T-cell lymphoma: A large series outcome analysis. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 787A-788A). AMER SOC HEMATOLOGY

Kyriakou, C; Thomson, K; D'Sa, S; Flory, A; Hanslip, J; Goldstone, AH; Yong, KL; (2005) Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma. BRIT J HAEMATOL , 129 (6) 763 - 770. 10.1111/j.1365-2141.2005.05521.x.

L

Lam, L; Diss, TC; Berisha, F; Idowu, BD; Gale, RE; Flanagan, AM; (2005) Differentiation between clear cell sarcoma and malignant melanoma using a molecular approach. In: JOURNAL OF PATHOLOGY. (pp. 5 - 5). JOHN WILEY & SONS LTD

Laurence, AD; Peggs, KS; (2005) Cerebral and pulmonary nocardia in a bone marrow transplant patient. Br J Haematol , 129 (6) 711-. 10.1111/j.1365-2141.2005.05474.x.

Lawrence, T; Puel, A; Relchenbach, J; Ku, CL; Chapgier, A; Renner, E; Minard-Colin, V; ... Casanova, JL; + view all (2005) Autosomal-dominant primary immunodeficiencies. CURRENT OPINION IN HEMATOLOGY , 12 (1) pp. 22-30. 10.1097/01.moh.0000149609.37309.0a.

Little, AM; Clever, S; Torres, HM; Marsh, SGE; Bronwen, S; Madrigal, A; (2005) Donor factors influencing unrelated volunteer donor selection for haematopoietic stem cell transplantation. In: (Proceedings) Joint Meeting of the American-Society-for-Blood-and-Marrow-Transplantation/Center-for-International-Blood-and-Marrow-Transplant-Research. (pp. p. 52). CARDEN JENNINGS PUBL CO LTD

M

Mackinnon, S; (2005) Reduced intensity allogeneic stem cell transplantation for relapsed Hodgkin and non-Hodgkin lymphoma lowers regimen toxicity and facilitates a graft-versus-lymphoma effect. In: ANNALS OF ONCOLOGY. (pp. 34 - 34). OXFORD UNIV PRESS

Manoussaka, MS; Memon, A; Nathwani, A; Porakishvili, N; Clark, E; Lydyard, PM; (2005) Toll like receptors (TLRs) in B cell chronic lymphocytic leukemia (B-CLL). In: BLOOD. (pp. 326B - 326B). AMER SOC HEMATOLOGY

Mansour, MR; Dogan, A; Morris, EC; Khwaja, A; Linch, DC; Mackinnon, S; Peggs, KS; (2005) Allogeneic transplantation for hepatosplenic allphabeta T-cell lymphoma. Bone Marrow Transplantation , 35 (9) pp. 824-829.

Mansour, MR; Dogan, A; Morris, EC; Khwaja, A; Linch, DC; Mackinnon, S; Peggs, KS; (2005) Allogeneic transplantation for hepatosplenic alpha beta T-cell lymphoma. BONE MARROW TRANSPL , 35 (9) 931 - 934. 10.1038/sj.bmt.1704897.

Mansour, MR; Linch, DC; Foroni, L; Goldstone, AH; Gale, RE; (2005) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukaemia. In: BLOOD. (pp. 417A - 418A). AMER SOC HEMATOLOGY

Mansouri, D; Adimi, P; Mirsaeidi, M; Mansouri, N; Khalilzadeh, S; Masjedi, MR; Adimi, P; ... Casanova, JL; + view all (2005) Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. EUROPEAN JOURNAL OF PEDIATRICS , 164 (12) pp. 753-757. 10.1007/s00431-005-1689-9.

Marden, CM; North, J; Anderson, R; Bakhsh, IA; Addison, E; Pittman, H; Mackinnon, S; (2005) CD69 is required for activated NK cell-mediated killing of resistant targets. In: BLOOD. (pp. 928A - 929A). AMER SOC HEMATOLOGY

Marks, A.J.; (2005) Targeting of cytotoxic peptides to haematological malignancies. Doctoral thesis , University of London. Green open access
file

Marks, AJ; Cooper, MS; Anderson, RJ; Orchard, KH; Hale, G; North, JM; Ganeshaguru, K; ... Wickremasinghe, RG; + view all (2005) Selective apoptotic killing of malignant hemopoietic cells by anti body-targeted delivery of an amphipathic peptide. CANCER RES , 65 (6) 2373 - 2377.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update August 2005. Int J Immunogenet , 32 (6) pp. 429-430. 10.1111/j.1744-313X.2005.00555.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update February 2005. Int J Immunogenet , 32 (3) 215-. 10.1111/j.1744-313X.2005.00518.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update January 2005. Int J Immunogenet , 32 (3) pp. 213-214. 10.1111/j.1744-313X.2005.00517.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update June 2005. TISSUE ANTIGENS , 66 (4) pp. 338-340. 10.1111/j.1399-0039.2005.00479.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update March 2005. Int J Immunogenet , 32 (3) pp. 217-218. 10.1111/j.1744-313X.2005.00520.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update October 2004. Int J Immunogenet , 32 (1) 71-. 10.1111/j.1744-313X.2005.00492.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update September 2005. Int J Immunogenet , 32 (6) pp. 431-432. 10.1111/j.1744-313X.2005.00556.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, updated July 2005. Int J Immunogenet , 32 (6) pp. 425-428. 10.1111/j.1744-313X.2005.00544.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; ... Trowsdale, J; + view all (2005) Nomenclature for Factors of the HLA System, 2004. Human Immunology , 66 pp. 571-636.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; ... Trowsdale, J; + view all (2005) Nomenclature for factors of the HLA system, 2004. TISSUE ANTIGENS , 65 (4) pp. 301-369. 10.1111/j.1399-0039.2005.00379.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; ... Trowsdale, J; + view all (2005) Nomenclature for factors of the HLA system, 2004. HUMAN IMMUNOLOGY , 66 (5) pp. 571-636. 10.1016/j.humimm.2005.02.002.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; ... Trowsdale, J; + view all (2005) Nomenclature for factors of the HLA system, 2004. Int J Immunogenet , 32 (2) pp. 107-159. 10.1111/j.1744-313X.2005.00509.x.

Marsh, SGE; WHO Nomenclature Committee, ; (2005) Nomenclature for factors of the HLA system, update August 2004. Hum Immunol , 66 (1) 92-. 10.1016/j.humimm.2004.10.011.

Marsh, SGE; WHO Nomenclature Committee, ; (2005) Nomenclature for factors of the HLA system, update September 2004. Hum Immunol , 66 (1) 93-. 10.1016/j.humimm.2004.10.012.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update December 2004. Hum Immunol , 66 (3) pp. 329-330. 10.1016/j.humimm.2005.01.016.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update November 2004. Hum Immunol , 66 (3) 328-. 10.1016/j.humimm.2005.01.015.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update October 2004. Hum Immunol , 66 (3) pp. 326-327. 10.1016/j.humimm.2005.01.014.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update April 2005. Int J Immunogenet , 32 (5) pp. 325-326. 10.1111/j.1744-313X.2005.00527.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update April 2005. Hum Immunol , 66 (9) pp. 1019-1021. 10.1016/j.humimm.2005.10.003.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update December 2004. Tissue Antigens , 65 (3) pp. 299-300. 10.1111/j.1399-0039.2005.00377.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update February 2005. Hum Immunol , 66 (9) pp. 1015-1016. 10.1016/j.humimm.2005.10.013.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update January 2005. Hum Immunol , 66 (9) pp. 1013-1014. 10.1016/j.humimm.2005.10.012.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update July 2005. Hum Immunol , 66 (11) pp. 1183-1186. 10.1016/j.humimm.2005.10.006.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update June 2005*. Int J Immunogenet , 32 (5) pp. 329-331. 10.1111/j.1744-313X.2005.00535.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update June 2005. Hum Immunol , 66 (9) pp. 1025-1027. 10.1016/j.humimm.2005.10.005.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update March 2005. Hum Immunol , 66 (9) pp. 1017-1018. 10.1016/j.humimm.2005.10.014.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update May 2005*. Int J Immunogenet , 32 (5) pp. 327-328. 10.1111/j.1744-313X.2005.00531.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update May 2005. Hum Immunol , 66 (9) pp. 1022-1024. 10.1016/j.humimm.2005.10.004.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update November 2004. Tissue Antigens , 65 (2) pp. 208-209. 10.1111/j.1399-0039.2005.00366.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update October 2004. Tissue Antigens , 65 (2) pp. 206-207. 10.1111/j.1399-0039.2005.00357.x.

Mauri, P; Scarpa, A; Nascimbeni, AC; Benazzi, L; Parmagnani, E; Mafficini, A; Della Peruta, M; ... Sorio, C; + view all (2005) Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J , 19 (7) 1125 - +. 10.1096/fj.04-3000fje.

Mayor, NP; Cox, ST; McWhinnie, AJ; Arguello, JR; Shaw, BE; Little, AM; Madrigal, JA; (2005) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). TISSUE ANTIGENS , 65 (1) 107 - 109. 10.1111/j.1399-0039.2004.00340.x.

Mayor, NP; Cox, ST; McWhinnie, AJ; Argüello, JR; Shaw, BE; Little, A-M; Madrigal, JA; (2005) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). Tissue Antigens , 65 (1) pp. 107-109. 10.1111/j.1399-0039.2005.00340.x.

McCabe, DJH; Harrison, P; Mackie, IJ; Sidhu, PS; Lawrie, AS; Purdy, G; Machin, SJ; (2005) Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. PLATELETS , 16 (5) 269 - 280. 10.1080/09537100400020567.

McCabe, DJH; Harrison, P; Mackie, IJ; Sidhu, PS; Lawrie, AS; Watt, H; Machin, SJ; (2005) Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis. J NEUROL NEUROSUR PS , 76 (9) 1249 - 1254. 10.1136/jnnp.2004.051003. Gold open access

McIntosh, J.H.; (2005) Investigations of the thrombin generation test for the measurement of factor VIII. Doctoral thesis , University of London. Green open access
file

Mehta, A; Cassiman, JJ; (2005) The pathophysiology of Fabry Disease. Acta Paediatrica , 94 (447) 79-.

Mehta, A; Ginsberg, L; FOS Investigators, ; (2005) Natural history of the cerebrovascular complications of Fabry disease. ACTA PAEDIATRICA , 94 24 - 27. 10.1080/08035320510028076.

Mehta, AB; Cassiman, JJ; (2005) Understanding genotype-phenotype correlations. Acta Paediatrica , 94 (447) 79-.

Millar, CM; Starke, R; Riddell, AF; Griffioen, A; Mackie, I; Brown, SA; (2005) Investigation of relationship of von Willebrand factor antigen clearance with ADAMTS-13 activity and Tyr1584Cys polymorphism in type 1 von Willebrand disease. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 46 - 46). BLACKWELL PUBLISHING

Miller, RF; Scully, M; Cohen, H; Roedling, S; Starke, R; Edwards, SG; Machin, S; (2005) Thrombotic thrombocytopaenic purpura in human immunodeficiency virus infected patients. International Journal of STD and AIDS , 16 pp. 538-542.

Miller, RF; Scully, M; Cohen, H; Roedling, S; Starke, R; Edwards, SG; Machin, SJ; (2005) Thrombotic thrombocytopaenic purpura in HIV-infected patients. INT J STD AIDS , 16 (8) 538 - 542.

Mills, KI; Gilkes, AF; Walsh, V; Sweeney, M; Austin, SJ; Gale, RE; (2005) FLT3 gene mutations in AML. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 29 - 29). BLACKWELL PUBLISHING

Morris, E; Mackinnon, S; (2005) Outcome following alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL). TRANSFUSION AND APHERESIS SCIENCE , 32 (1) 73 - 83. 10.1016/j.transci.2004.10.008.

Morris, EC; Mackinnon, S; (2005) Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma. BEST PRACT RES CL HA , 18 (1) 129 - 142. 10.1016/j.beha.2004.08.015.

N

Narat, S; Gandla, J; Dogan, A; Mehta, A; (2005) Successful treatment of hairy cell leukemia variant with rituximab. Leukemia and Lymphoma , 48 (8) pp. 1229-1232.

Narat, S; Gandla, J; Hoffbrand, AV; Hughes, RG; Mehta, AB; (2005) Rituximab in the treatment of refractory autoimmune cytopenias in adults. Haematologica , 90 (9) pp. 1273-1274. Gold open access

Nathwani, AC; Davidoff, AM; Linch, DC; (2005) A review of gene therapy for haematological disorders. British Journal of Haematology , 128 (1) pp. 3-17. 10.1111/j.1365-2141.2004.05231.x.

Nathwani, AC; Davidoff, AM; Linch, DC; (2005) A review of gene therapy for haematological disorders. BRIT J HAEMATOL , 128 (1) 3 - 17. 10.1111/j.1365-2141.05231.x.

Nathwani, AC; Davidoff, AM; Linch, DC; (2005) A review of gene therapy for haematological disorders. Br J Haematol , 128 (1) pp. 3-17. 10.1111/j.1365-2141.2004.05231.x.

Nathwani, AC; McIntosh, J; Davidoff, AM; (2005) An update on gene therapy for hemophilia. Current hematology reports , 4 (4) pp. 287-293.

Nathwani, AC; McIntosh, J; Davidoff, AM; (2005) An update on gene therapy for hemophilia. Curr Hematol Rep , 4 (4) pp. 287-293.

O

O'Brien, F; Sekhavat, M; Lowdell, M; (2005) Long-term storage of cryopreserved autologous bone marrow retains viable haematopoietic progenitor cells. In: (Proceedings) 31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group. (pp. S110-S110). NATURE PUBLISHING GROUP

O'Doherty, A; Ruf, S; Mulligan, C; Hildreth, V; Errington, ML; Cooke, S; Sesay, A; ... Fisher, EMC; + view all (2005) An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. SCIENCE , 309 (5743) 2033 - 2037. 10.1126/science.1114535.

O'Donnell, M.W.; (2005) Lipidic peptide dendrimers: Potential gene delivery agents for the treatment of haemophilia B. Doctoral thesis , University of London. Green open access
file

Oakervee, HE; Popat, R; Curry, N; Smith, P; Morris, C; Drake, M; Agrawal, S; ... Cavenagh, JD; + view all (2005) PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 129 (6) pp. 755-762. 10.1111/j.1365-2141.2005.05519.x.

P

Pallis, M; Truran, L; Grundy, M; Fisher, J; Hills, R; Moorman, A; Hoy, T; ... Russell, NBA; + view all (2005) Functional p-glycoprotein and internal tandem duplications of FLT3 are characteristic of discrete populations of elderly AML patients. British Journal of Haematology , 129 39-.

Pascolo, S; Ginhoux, F; Laham, N; Walter, S; Schoor, O; Probst, J; Rohrlich, P; ... Rammensee, H-G; + view all (2005) The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells. Int Immunol , 17 (2) pp. 117-122. 10.1093/intimm/dxh191.

Peggs, K.S.; Hunter, A.; Chopra, R.; Parker, A.; Mahendra, P.; Milligan, D.; Craddock, C.; ... Mackinnon, S.; + view all (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. The Lancet , 365 (9475) pp. 1934-1941. 10.1016/S0140-6736(05)66659-7.

Peggs, KS; (2005) The role of alemtuzumab in allogeneic stem cell transplantation. In: Hillmen, P and Witzig, TE, (eds.) Therapeutic Strategies in Lymphoid Malignancy. (pp. 177-188). Informa HealthCare

Peggs, KS; Allison, JP; (2005) Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily. BRIT J HAEMATOL , 130 (6) 809 - 824.

Peggs, KS; Hunter, A; Chopra, R; Parker, A; Mahendra, P; Milligan, D; Craddock, C; ... MacKinnon, S; + view all (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet , 365 (9475) pp. 1934-1941. 10.1016/S0140-6736(05)66659-7.

Peggs, KS; Hunter, A; Chopra, R; Parker, A; Mahendra, P; Milligan, D; Craddock, C; ... Mackinnon, S; + view all (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. LANCET , 365 (9475) 1934 - 1941.

Peggs, KS; Mackinnon, S; Linch, DC; (2005) The role of allogeneic transplantation in non-Hodgkin's lymphoma. BRIT J HAEMATOL , 128 (2) 153 - 168. 10.1111/j.1365-2141.2004.05251.x.

Pennell, DJ; Anderson, LJ; Paul, K; Forni, GL; Ellis, G; Walker, JM; Porter, JB; (2005) Calibration of myocardial T2*values in post-mortem hearts. In: BLOOD. (pp. 40B - 40B). AMER SOC HEMATOLOGY

Popat, R; Goff, L; Oaekervee, HE; Cavenagh, JD; Joel, SP; (2005) Changes in Mcl-1 and Bim expression with bortezomib and melphalan therapy for multiple myeloma. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 697A-697A). AMER SOC HEMATOLOGY

Popat, R; Oakervee, H; Foot, N; Curry, N; Morris, C; Drake, M; Agrawal, S; ... Cavenagh, JD; + view all (2005) PAD (PS-341/bortezomib, adriamycin and dexamethasone) as front-line therapy for untreated patients with multiple myeloma. In: (Proceedings) 45th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 22). BLACKWELL PUBLISHING

Popat, R; Oakervee, HE; Agrawal, S; Smith, P; Singer, C; Craddock, C; Williams, C; ... Cavenagh, JD; + view all (2005) A phase I/II trial of bortezomib and low dose intravenous melphalan (BM) for relapsed multiple myeloma. In: (Proceedings) 45th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 27). BLACKWELL PUBLISHING

Popat, R; Oakervee, HE; Curry, N; Foot, N; Morris, C; Drake, M; Agrawal, S; ... Cavenagh, JD; + view all (2005) Reduced dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 717A-718A). AMER SOC HEMATOLOGY

Popat, R; Oakervee, HE; Foot, N; Agrawal, S; Smith, P; Craddock, C; Williams, C; ... Cavenagh, JD; + view all (2005) A phase I/II study of bortezomib and low dose intravenous melphalan (BM) for relapsed multiple myeloma. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 718A-718A). AMER SOC HEMATOLOGY

Porakishvili, N; Kulikova, N; Jewell, AP; Youinou, PY; Nedelec, S; Yong, K; Nathwani, A; ... Lydyard, PM; + view all (2005) CD180 is more highly expressed by B cell chronic lymphocytic leukaemia (B-CLL) cells using IgVh mutated than those using IgVh unmutated genes. British Journal of Haematology , 131 (3) pp. 313-319.

Porter, JB; (2005) Liver iron measurement by MRI. BLOOD , 105 (2) 437 - 438.

Porter, JB; (2005) Monitoring and treatment of iron overload: State of the art and new approaches. SEMIN HEMATOL , 42 (2) S14 - S18. 10.1053/j.seminhematol.2005.01.004.

Porter, JB; Rafique, R; Srichairatanakool, S; Davis, BA; Shah, FT; Hair, T; Evans, P; (2005) Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical use. COOLEY'S ANEMIA EIGHTH SYMPOSIUM , 1054 155 - 168. 10.1196/annals.1345.018.

Porter, JB; Tanner, MA; Pennell, DJ; Eleftheriou, P; (2005) Improved myocardial T2*in transfusion dependent anemias receiving ICL670 (Deferasirox). In: BLOOD. (pp. 1003A - 1003A). AMER SOC HEMATOLOGY

Pule, MA; Straathof, KC; Dotti, G; Heslop, HE; Rooney, CM; Brenner, MK; (2005) A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells. MOLECULAR THERAPY , 12 (5) pp. 933-941. 10.1016/j.ymthe.2005.04.016.

Q

Quezada, SA; Bennett, K; Blazar, BR; Rudensky, AY; Sakaguchi, S; Noelle, RJ; (2005) Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: The interplay of clonal anergy and immune regulation. J IMMUNOL , 175 (2) 771 - 779.

R

Raghavan, M; Gale, RE; Skoulakis, S; Chaplin, T; Molloy, GY; Linch, DC; Burnett, AK; (2005) An increased frequency of abnormalities including uniparental disomy is detected by SNP array compared with conventional karyotype analysis in acute myeloid leukemia. In: BLOOD. (pp. 33A - 33A). AMER SOC HEMATOLOGY

Rew, SB; Peggs, K; Sanjuan, I; Pizzey, AR; Koishihara, Y; Kawai, S; Kosaka, M; ... Yong, KL; + view all (2005) Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24. CLIN CANCER RES , 11 (9) 3377 - 3384.

Roberts, CH; Madrigal, JA; Marsh, SGE; (2005) Cloning and sequencing entire KIR genes from genomic DNA. In: (Proceedings) 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops. (pp. p. 525). BLACKWELL PUBLISHING

Robinson, J; Waller, MJ; Stoehr, P; Marsh, SGE; (2005) IPD - the immuno polymorphism database. NUCLEIC ACIDS RESEARCH , 33 D523-D526. 10.1093/nar/gki032. Gold open access

Robinson, J.; Waller, M.J.; Stoehr, P.; Marsh, S.G.E.; (2005) IPD - the Immuno Polymorphism Database. Nucleic Acids Research , 33 (Databa) D523-D526. 10.1093/nar/gki032. Green open access
file

Rodriguez, T; Mendez, R; Roberts, CH; Ruiz-Cabello, F; Dodi, IA; Nevot, MAL; Paco, L; ... Garrido, F; + view all (2005) High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity. CANCER IMMUNOLOGY IMMUNOTHERAPY , 54 (2) pp. 141-148. 10.1007/s00262-004-0561-5.

Rowe, J.M.; Buck, G.; Burnett, A.K.; Chopra, R.; Wiernik, P.H.; Richards, S.M.; Lazarus, H.M.; ... Goldstone, A.H.; + view all (2005) Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood , 106 (12) pp. 3760-3767. 10.1182/blood-2005-04-1623. Green open access
file

Rowe, JM; Buck, G; Burnett, AK; Chopra, R; Wiernik, PH; Richards, SM; Lazarus, HM; ... Goldstone, AH; + view all (2005) ECOG; MRC/NCRI Adult Leukemia Working Party. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood , 106 (12) pp. 3760-3767. 10.1182/blood-2005-04-1623.

Rubio, MT; Means, TK; Chakraverty, R; Shaffer, J; Fudaba, Y; Chittenden, M; Luster, AD; (2005) Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E-2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE(2) in chemokine and cytokine expression by MoDCs. INTERNATIONAL IMMUNOLOGY , 17 (12) pp. 1561-1572. 10.1093/intimm/dxh335.

Rusakiewicz, Sylvie; (2005) Development of epitope-based immunotherapy for the treatment of chronic myeloid leukaemia. Doctoral thesis , UCL (University College London). Green open access
file

S

Sabin, CA; Phillips, AN; Yee, TT; Griffioen, A; Lee, CA; (2005) Twenty five years of HIV infection in haemophilic men in Britain: an observational study. BRIT MED J , 331 (7523) 997 - 998. 10.1136/bmj.38604.468785.DE. Gold open access

Samuel, E; Sekhavat, M; O'Brien, F; Pang, K; Ankrah, J; Mackinnon, S; Lowdell, M; (2005) Effect of conditioning regimen on the relationship between CD34 cell dose and time to engraftment after allogeneic stem cell transplant. In: BONE MARROW TRANSPLANTATION. (pp. S109 - S109). NATURE PUBLISHING GROUP

Schaefer, E; Mehta, A; Gal, A; (2005) Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey. Acta Paediatrica , 94 (Suppl 44) pp. 87-92. 10.1080/08035320510031045.

Schaefer, E; Mehta, A; Gal, A; (2005) Vascular complications of Fabry disease: enzyme replacement and other therapies. Acta Paediatrica - Supplement , 94 (447) pp. 87-92.

Schafer, E; Baron, K; Widmer, U; Deegan, P; Neumann, HP; Sunder-Plassmann, G; Johansson, JO; ... Gal, A; + view all (2005) Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease. Human Mutation , 25 (4) 412-.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, M; Noreen, HJ; Setterholm, M; (2005) The HLA Dictionary 2004: a summary of HLA-A, -B, -C,-DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLAA -B, -C, -DR and -DQ antigens. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 32 (1) pp. 19-69. 10.1111/j.1744-313X.2005.00497.x.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, M; Noreen, HJ; Setterholm, M; (2005) The HLA Dictionary 2004: a summary of HLA-A, -B, -C,-DRB1/3/4/5 and-DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. TISSUE ANTIGENS , 65 (1) pp. 1-55. 10.1111/j.1399-0039.2004.00350.x.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, M; Noreen, HJ; Setterholm, M; (2005) The HLA dictionary 2004: A summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens , 65 (1) pp. 1-55. 10.1111/j.1399-0039.2005.00350.x.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, MA; Noreen, HJ; Setterholm, M; (2005) HLA dictionary 2004: summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Hum Immunol , 66 (2) pp. 170-210. 10.1016/j.humimm.2004.09.017.

Schwarting, A; Dehout, F; Feriozzi, S; Beck, M; Mehta, A; Widmer, U; Sunder-Plassmann, G; (2005) Agalsidase alfa prevents the decline in renal function in patients with Fabry disease. Nephrology Dialysis Transplantation , 20 V248-.

Scully, M; Cavenagh, J; Hagger, D; Benjamin, S; Mackie, I; Mchin, SJ; Cohen, H; (2005) Normalisation of ADAMTS 13 activity and disappearance of ADAMTS 13 antibody following rituximab in acute refractory thrombotic thrombocytopenic purpura. In: BLOOD. (pp. 357A - 358A). AMER SOC HEMATOLOGY

Scully, M; Miller, R; Cohen, H; Roedling, S; Edwards, S; Machin, SJ; (2005) Management of HIV associated thrombotic thrombocytopenic purpura. In: BLOOD. (pp. 845A - 845A). AMER SOC HEMATOLOGY

Scully, M; Miller, R; Cohen, H; Roedling, S; Starke, R; Edwards, S; Mackie, I; (2005) Treatment of HIV associated thrombotic thrombocytopenic purpura - importance of prompt diagnosis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 12 - 12). BLACKWELL PUBLISHING

Scully, M; Starke, R; Flynn, M; Haggar, D; Mackie, I; Machin, S; Cohen, H; (2005) Use of Rituximab in acute refractory thrombotic thrombocytopenic purpura. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 45 - 45). BLACKWELL PUBLISHING

Scully, M; Starke, R; Flynn, M; Haggar, D; Mackie, IJ; Machin, S; Cohen, H; (2005) Use of rituximab in acute refractory thrombotic thrombocytopenic purpura. In: (Proceedings) British society for haematology annual scientific meeting.

Scully, M; Starke, R; Lee, R; Mackie, I; Machin, SJ; Cohen, H; (2005) Successful pregnancy outcome in 5 patients with thrombotic thrombocytopenic purpura. In: BLOOD. (pp. 845A - 845A). AMER SOC HEMATOLOGY

Seldon, PM; Meja, KK; Giembycz, MA; (2005) Rolipram, salbutamol and prostaglandin E2 suppress TNFalpha release from human monocytes by activating Type II cAMP-dependent protein kinase. Pulm Pharmacol Ther , 18 (4) pp. 277-284. 10.1016/j.pupt.2004.12.012.

Sepulveda, C.A.G.; (2005) Killer cell Immunoglobulin-like Receptor (KIR) polymorphism: Functional implications and clinical relevance. Doctoral thesis , University of London. Green open access
file

Shah, JS; Hughes, D; Tayebjee, MH; MacFadyen, R; Mehta, A; Elliott, PM; (2005) Extracellular matrix turnover in patients with Anderson-Fabry disease. In: EUROPEAN HEART JOURNAL. (pp. 398 - 398). OXFORD UNIV PRESS

Shah, JS; Hughes, DA; Sachdev, B; Tome, M; Ward, D; Lee, P; Mehta, AB; (2005) Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. AM J CARDIOL , 96 (6) 842 - 846. 10.1016/j.amjcard.2005.05.033.

Shah, JS; Hughes, DA; Sachdev, B; Tome, M; Ward, D; Lee, P; Mehta, AB; (2005) Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. The American Journal of Cardiology , 96 (6) pp. 842-846.

Shah, JS; Lee, P; Hughes, D; Thaman, R; Sachdev, B; Pellerin, D; Mehta, A; (2005) The natural history of left ventricular systolic function in Anderson-Fabry disease. HEART , 91 (4) 533 - 534. 10.1136/hrt.2004.035584.

Shah, JS; Tayabjee, MH; Hughes, D; Mehta, A; McFadyen, R; Elliott, PM; (2005) Disease severity and abnormal collagen turn over in Anderson Fabry disease (AFD). In: HEART. (pp. A70 - A70). B M J PUBLISHING GROUP

Shaw, BE; Barber, LD; Mayor, NP; Marsh, SGE; Madrigal, JA; (2005) HLA-DPB1 specific responses between unrelated individuals can be demonstrated by the production of interferon gamma in an ELISpot assay. In: BONE MARROW TRANSPLANTATION. (pp. S140 - S141). NATURE PUBLISHING GROUP

Shaw, BE; Byrne, JL; Das-Gupta, E; Carter, I; Russell, NH; (2005) Converting mixed chimerism to full donor chimerism in recipients of campath-containing reduced intensity transplants reduces the relapse risk and results in significantly improved survival compared to those with persistent full donor chimerism. In: BLOOD. (pp. 573A - 573A). AMER SOC HEMATOLOGY

Shaw, BE; Gilyead, M; Das-Gupta, E; Byrne, JL; (2005) The use of HLA mismatched, bone marrow derived haematopoietic stem cells is significantly associated with primary non-engraftment in recipients of reduced-intensity conditioned transplants from unrelated donors. In: BONE MARROW TRANSPLANTATION. (pp. S202 - S202). NATURE PUBLISHING GROUP

Shaw, BE; Gilyead, M; Das-Gupta, E; Madrigal, JA; Byrne, JL; Russell, NH; (2005) Donor factors are significantly associated with primary non-engraftment in recipients of reduced intensity conditioned (RIC) transplants from unrelated donors. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 41 - 41). BLACKWELL PUBLISHING

Shaw, BE; Marsh, SGE; Mayor, NP; Madrigal, A; (2005) Particular HLA-DPB1 allele mismatches predict for worse overall survival in recipients of unrelated donor haematopoietic stem cell transplants. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. (pp. 13 - 13). CARDEN JENNINGS PUBL CO LTD

Shaw, BE; Russell, NH; Devereux, S; Das-Gupta, E; MacKinnon, S; Madrigal, JA; Pagliuca, A; ... Byrne, JL; + view all (2005) The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors. HAEMATOL-HEMATOL J , 90 (11) 1562 - 1569. Gold open access

Shaw, BE; Russell, NH; Devereux, S; Emma, DG; Stephen, M; Madrigal, JA; Pagliuca, A; ... Byrne, JL; + view all (2005) Single HLA allele mismatches are well tolerated in the recipients of T cell depleted reduced intensity conditioned transplants from unrelated donors. In: BLOOD. (pp. 812A - 812A). AMER SOC HEMATOLOGY

Simon, M; Grandage, VL; Linch, DC; Khwaja, A; (2005) Constitutive activation of the Wnt/ss-catenin signalling pathway in acute myeloid leukaemia. ONCOGENE , 24 (14) 2410 - 2420. 10.1038/sj.onc.1208431.

Simon, M; Grandage, VL; Linch, DC; Khwaja, A; (2005) Constitutive activation of the Wnt/β-catenin signalling pathway in acute myeloid leukaemia. Oncogene , 24 (14) pp. 2410-2420. 10.1038/sj.onc.1208431.

Stainsby, D; Cohen, H; Jones, H; (2005) The 2004 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Stainsby, D; Jones, H; Chapman, J; Hick, R; Cohen, H; (2005) Understanding SHOT data: encouraging active participation and putting the findings into context. Presented at: British society for haematology annual scientific meeting, Manchester.

Stainsby, D; Russell, J; Cohen, H; Lilleyman, J; (2005) Reducing adverse events in blood transfusion. British journal of haematology , 131 pp. 8-12.

Starke, R; Harrison, P; Mackie, I; Wang, G; Erusalimsky, JD; Gale, R; Masse, JM; ... Machin, S; + view all (2005) The expression of prion protein (PrPc) in the megakaryocyte lineage. J THROMB HAEMOST , 3 (6) 1266 - 1273.

Starke, R; Harrison, P; Mackie, I; Wang, G; Erusalimsky, JD; Gale, R; Massé, JM; ... Machin, S; + view all (2005) The expression of prion protein (PrP<sup>C</sup>) in the megakaryocyte lineage. Journal of Thrombosis and Haemostasis , 3 (6) pp. 1266-1273. 10.1111/j.1538-7836.2005.01343.x.

Starke, R; Mackie, I; Purdy, G; Scully, M; Machin, S; (2005) The sensitive detection of antibodies to von Willebrand factor cleaving protease (ADAMTS-13). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 17 - 17). BLACKWELL PUBLISHING

Steele, AJ; Al-Chalabi, A; Ferrante, K; Cudkowicz, ME; Brown, RH; Garson, JA; (2005) Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. NEUROLOGY , 64 (3) 454 - 458.

Stigliano, R; Marelli, L; Pang, K; Lowdell, M; Rolles, K; Patch, D; Burroughs, AK; (2005) G-CSF mobilization of bone marrow-derived hepatocye and haematopoietic progenitors in acute alcoholic hepatitis - A randomised controlled trial. Preliminary data. HEPATOLOGY , 42 (4) 741A-741A.

Stigliano, R; Marelli, L; Senzolo, M; Pang, C; Lowdell, M; Patch, D; Rolles, K; ... Burroughs, AK; + view all (2005) Peripheral hepatic and haematopoietic stem cells after partial hepatectomy: Preliminary data. GUT , 54 A48-A48.

Stigliano, R; Marelli, L; Senzolo, M; Pang, K; Lowdell, M; Davies, N; Tibballs, J; ... Burroughs, AK; + view all (2005) Are CD34+ cells increased in perpheral blood of patients with HCC. Preliminary data. HEPATOLOGY , 42 (4) 742A-743A.

Stigliano, R; Morelli, L; Senzolo, M; Morisco, F; Pang, C; Lowdell, M; Patch, D; ... Burroughs, AK; + view all (2005) Circulating progenitor cells after vascular injury. GUT , 54 A48-A49.

Straathof, KC; Pule, MA; Yotnda, P; Dotti, G; Vanin, EF; Brenner, MK; Heslop, HE; ... Rooney, CM; + view all (2005) An inducible caspase 9 safety switch for T-cell therapy. BLOOD , 105 (11) pp. 4247-4254. 10.1182/blood-2004-11-4564. Green open access
file

Streck, CJ; Dickson, PV; Catherine, YIG; Zhou, JF; Gray, JT; Nathwani, AC; Davidoff, AM; (2005) Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models. CLIN CANCER RES , 11 (16) 6020 - 6029. 10.1158/1078-0432.CCR-05-0502.

Streck, CJ; Ng, CYC; Zhang, YB; Zhou, JF; Nathwani, AC; Davidoff, AM; (2005) Interferon-mediated anti-angiogenic therapy for neuroblastoma. CANCER LETT , 228 (1-2) 163 - 170. 10.1016/j.canlet.2004.11.063.

Streck, CJ; Zhang, YB; Zhou, JF; Ng, C; Nathwani, AC; Davidoff, AM; (2005) Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. JOURNAL OF PEDIATRIC SURGERY , 40 (1) 236 - 243. 10.1016/j.jpedsurg.2004.09.049.

Stuart-Smith, SE; Hughes, DA; Bain, BJ; (2005) Are routine iron stains on bone marrow trephine biopsy specimens necessary? JOURNAL OF CLINICAL PATHOLOGY , 58 (3) pp. 269-272. 10.1136/jcp.2004.017038.

Stubbs, M; Khan, K; Wickremasinghe, RG; Ganeshaguru, K; Caplin, ME; (2005) CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines. Oncology Reports , 14 (4) pp. 1055-1058.

Stubbs, M; Khan, K; Wickremasinghe, RG; Ganeshaguru, K; Caplin, ME; (2005) CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines. ONCOL REP , 14 (4) 1055 - 1058.

T

Tan, SV; Lee, PJ; Walters, RJL; Mehta, A; Bostock, H; (2005) Evidence for motor axon depolarization in Fabry disease. MUSCLE & NERVE , 32 (4) 548 - 551. 10.1002/mus.20390.

Tanner, MA; Porter, JB; Westwood, MA; Nair, SV; Anderson, LJ; Walker, JM; Pennell, DJ; (2005) Myocardial T2*in patients with cardiac failure secondary to iron overload. In: BLOOD. (pp. 40B - 40B). AMER SOC HEMATOLOGY

Tauro, S; Craddock, C; Peggs, K; Begum, G; Mahendra, P; Cook, G; Marsh, J; ... Mackinnon, S; + view all (2005) Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia. J CLIN ONCOL , 23 (36) 9387 - 9393. 10.1200/JCO.2005.02.0057.

Tauro, S; Mackinnon, S; Peggs, K; Begum, G; Mahendra, P; Cook, G; Marsh, J; ... Craddock, C; + view all (2005) Allogeneic stem cell transplantation using a reduced intensity conditioning (RIC) regimen has the capacity to produce durable remissions and long term disease-free survival in patients with high risk acute myeloid leukemia (AML). In: BLOOD. (pp. 332A - 332A). AMER SOC HEMATOLOGY

Thomson, KJ; Hart, DP; Banerjee, L; Ward, KN; Peggs, KS; Mackinnon, S; (2005) The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. BONE MARROW TRANSPL , 35 (11) 1065 - 1069. 10.1038/sj.bmt.1704959.

Thomson, KJ; Morris, EC; Milligan, D; Cook, G; Cavet, J; Craddock, C; Hunter, A; ... Mackinnon, S; + view all (2005) Reduced intensity allogeneic transplantation for non-Hodgkin's Lymphoma: Extended follow-up of an alemtuzumab-containing regimen. In: BLOOD. (pp. 120A - 121A). AMER SOC HEMATOLOGY

Thomson, KJ; Peggs, KS; (2005) Role of allogeneic stem cell transplantation in multiple myeloma. EXPERT REV ANTICANC , 5 (3) 455 - 464. 10.1586/14737140.5.3.455.

Thomson, KJ; Peggs, KS; Morris, EC; Khwaja, A; Linch, DC; Goldstone, AH; Mackinnon, S; (2005) Allogeneic stem cell transplantation for high-risk acute myeloid leukemia: No increase in relapse with alemtuzumab-depleted grafts. In: BLOOD. (pp. 581A - 581A). AMER SOC HEMATOLOGY

Thomson, KJ; Peggs, KS; Morris, EC; Khwaja, A; Linch, DC; Goldstone, AH; Mackinnon, S; (2005) Allogeneic stem cell transplantation with T cell depletion for acute myeloid leukaemia. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 35 - 36). BLACKWELL PUBLISHING

Thomson, KJ; Peggs, KS; Smith, P; Chopra, R; Cavet, J; Hunter, A; Parker, A; ... Mackinnon, S; + view all (2005) Improved outcome following reduced intensity allogeneic transplantation in Hodgkin's lymphoma relapsing post-autologous transplantation. In: BLOOD. (pp. 194A - 194A). AMER SOC HEMATOLOGY

Thomson, KJ; Peggs, KS; Sureda, A; Hunter, A; Caballero, MD; Cavet, J; Urbano-Ispizua, A; ... Mackinnon, S; + view all (2005) Impact of in vivo T cell depletion on outcome following reduced intensity transplantation with matched related donors for Hodgkin lymphoma: comparison between two prospective studies. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 34 - 34). BLACKWELL PUBLISHING

Torres, HM; Robinson, J; Madrigal, JA; Marsh, SGE; (2005) Cactus, a population genetics analysis environment. In: (Proceedings) 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops. (pp. p. 486). BLACKWELL PUBLISHING

Tsuzuki, S; Hong, DL; Eguchi, M; Eguchi, M; Greaves, M; Brown, J; Gupta, R; (2005) Developmental impact of leukaemia associated fusion genes on stem cell fate. In: (Proceedings) 14th Conference on Hemoglobin Switching. (pp. p. 85). ACADEMIC PRESS INC ELSEVIER SCIENCE

V

Verfuerth, S; Pizzey, AR; Chow, SLC; Chowdhry, N; Mackinnon, S; (2005) In vitro expansion of CMV-specific T cells from CMV seronegative donors. In: BLOOD. (pp. 62B - 62B). AMER SOC HEMATOLOGY

Vichinsky, E; Fischer, R; Fung, E; Onyekwere, O; Porter, J; Swerdlow, P; Coates, T; ... Marks, P; + view all (2005) A randomized, controlled phase II trial in sickle cell disease patients with chronic iron overload demonstrates that the once-daily oral iron chelator deferasirox (Exjade((R)) ICL670) is well tolerated and reduces iron burden. In: BLOOD. (pp. 95A - 95A). AMER SOC HEMATOLOGY

Vichinsky, E; Fischer, R; Pakbaz, Z; Onyekwere, O; Porter, J; Swerdlow, P; Coates, T; ... Marks, P; + view all (2005) Satisfaction and convenience of chelation therapy in patients with sickle cell disease (SCD): Comparison between deferasirox (Exjade((R)), ICL670) and deferoxamine (DFO). In: BLOOD. (pp. 656A - 657A). AMER SOC HEMATOLOGY

Vogt, G; Chapgier, A; Yang, K; Chuzhanova, N; Feinberg, J; Fieschi, C; Boisson-Dupuis, S; ... Casanova, JL; + view all (2005) Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. NATURE GENETICS , 37 (7) pp. 692-700. 10.1038/ng1581.

W

Walter, P; Macklin, E; Porter, J; Evans, P; Coates, T; Olivieri, NF; Giardina, P; ... Harmatz, P; + view all (2005) Control of oxidant-stress and inflammation by iron chelators deferasirox (ICL670) or deferoxamine in beta-thalassemia: An ancillary study of the novartis CICL670A0107 trial. In: BLOOD. (pp. 1003A - 1003A). AMER SOC HEMATOLOGY

Walton, J; Lawson, K; Manoussaka, MS; Nathwani, A; Emory, V; Lydyard, PM; Porakishvili, N; (2005) CD4(+) perforin(+) T cells in B-CLL: MHC class II restriction and anti-cytomegalovirus reactivity. In: BLOOD. (pp. 325B - 326B). AMER SOC HEMATOLOGY

Westerman, MP; Pizzey, A; Hirshman, J; Cerino, M; Eze, A; Lawrie, A; Purdie, G; ... Porter, J; + view all (2005) Hydroxyurea treated sickle disorders demonstrate decreased plasma Hb, red cell vesicles and thrombolysis. In: BLOOD. (pp. 653A - 653A). AMER SOC HEMATOLOGY

Westwood, MA; Wonke, B; Maceira, AM; Prescott, E; Walker, JM; Porter, JB; Pennell, DJ; (2005) Left ventricular diastolic function compared with T2*cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major. J MAGN RESON IMAGING , 22 (2) 229 - 233. 10.1002/jmri.20379.

Whitelegg, AM; Oosten, LE; Jordan, S; Kester, M; van, HAG; Madrigal, JA; Goulmy, E; ... L, ; + view all (2005) Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers. The Journal of Immunology , 175 (3) pp. 1706-1714.

Williams, KE; Gardiner, C; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 57 - 57). BLACKWELL PUBLISHING

Williams, KE; Gardiner, C; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study. In: (Proceedings) British society for haematology annual scientific meeting.

Winter, M; Keeling, D; Sharpen, F; Cohen, H; Vallance, P; Haemostasis, ; Thrombosis Task Force of the British Committee for Standards in, H; (2005) Procedures for the outpatient management of patients with deep venous thrombosis. Clinical and laboratory haematology , 27 pp. 61-66.

Y

Yarranton, H; Lawrie, AS; Mackie, IJ; Pinkoski, L; Corash, L; Machin, SJ; (2005) Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light. TRANSFUSION , 45 (9) 1453 - 1458. 10.1111/j.1537-2995.2005.00551.x.

Yarranton, H.; Lawrie, A.S.; Mackie, I.J.; Pinkoski, L.; Corash, L.; Machin, S.J.; (2005) Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light. Transfusion , 45 (9) pp. 1453-1458. 10.1111/j.1537-2995.2005.00551.x.

This list was generated on Sun May 26 05:04:23 2019 BST.